THC Biomed Valuation
| THCBF Stock | USD 0 0.00 0.00% |
THC Biomed seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of THC Biomed Intl from evaluating the company fundamentals such as return on equity of -0.41, and Current Valuation of 6.56 M as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that THC Biomed's price fluctuation is out of control at this time. Calculation of the real value of THC Biomed Intl is based on 3 months time horizon. Increasing THC Biomed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the THC pink sheet is determined by what a typical buyer is willing to pay for full or partial control of THC Biomed Intl. Since THC Biomed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of THC Pink Sheet. However, THC Biomed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 9.6E-4 | Hype 6.08E-4 |
The real value of THC Pink Sheet, also known as its intrinsic value, is the underlying worth of THC Biomed Intl Company, which is reflected in its stock price. It is based on THC Biomed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of THC Biomed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of THC Biomed Intl helps investors to forecast how THC pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of THC Biomed more accurately as focusing exclusively on THC Biomed's fundamentals will not take into account other important factors: THC Biomed Total Value Analysis
THC Biomed Intl is at this time forecasted to have takeover price of 6.56 M with market capitalization of 8.59 M, debt of 858.43 K, and cash on hands of 1.16 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the THC Biomed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.56 M | 8.59 M | 858.43 K | 1.16 M |
THC Biomed Investor Information
About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. THC Biomed Intl recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from THC Biomed's historical financial statements, THC Biomed Intl is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.THC Biomed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. THC Biomed has an asset utilization ratio of 22.65 percent. This implies that the Company is making $0.23 for each dollar of assets. An increasing asset utilization means that THC Biomed Intl is more efficient with each dollar of assets it utilizes for everyday operations.THC Biomed Ownership Allocation
THC Biomed Intl secures a total of 163.96 Million outstanding shares. THC Biomed Intl shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.THC Biomed Profitability Analysis
The company reported the revenue of 3.34 M. Net Loss for the year was (3.07 M) with loss before overhead, payroll, taxes, and interest of (1.03 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates THC Biomed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in THC Biomed and how it compares across the competition.
About THC Biomed Valuation
The pink sheet valuation mechanism determines THC Biomed's current worth on a weekly basis. Our valuation model uses a comparative analysis of THC Biomed. We calculate exposure to THC Biomed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of THC Biomed's related companies.THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.
8 Steps to conduct THC Biomed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates THC Biomed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct THC Biomed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain THC Biomed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine THC Biomed's revenue streams: Identify THC Biomed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research THC Biomed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish THC Biomed's growth potential: Evaluate THC Biomed's management, business model, and growth potential.
- Determine THC Biomed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate THC Biomed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
THC Biomed Growth Indicators
Investing in growth stocks can be very risky. If the company such as THC Biomed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 163.9 M | |
| Retained Earnings | -25.3 M |
Complementary Tools for THC Pink Sheet analysis
When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |